(Q46123661)

English

Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial

scientific article published in January 2009

In more languages
default for all languages
No label defined

No description defined

Statements

Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial (English)
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit